Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 4
2017 1
2018 4
2019 7
2020 4
2021 1
2022 4
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Risk-Stratified Therapy for Pediatric Acute Myeloid Leukemia.
Tomizawa D, Tsujimoto SI. Tomizawa D, et al. Among authors: tsujimoto si. Cancers (Basel). 2023 Aug 18;15(16):4171. doi: 10.3390/cancers15164171. Cancers (Basel). 2023. PMID: 37627199 Free PMC article. Review.
Prevalence of pathogenic variants in cancer-predisposing genes in second cancer after childhood solid cancers.
Yoshida M, Nakabayashi K, Yang W, Sato-Otsubo A, Tsujimoto SI, Ogata-Kawata H, Kawai T, Ishiwata K, Sakamoto M, Okamura K, Yoshida K, Shirai R, Osumi T, Kiyotani C, Shioda Y, Terashima K, Ishimaru S, Yuza Y, Takagi M, Arakawa Y, Imamura T, Hasegawa D, Inoue A, Yoshioka T, Ito S, Tomizawa D, Koh K, Matsumoto K, Kiyokawa N, Ogawa S, Manabe A, Niwa A, Hata K, Yang JJ, Kato M. Yoshida M, et al. Among authors: tsujimoto si. Cancer Med. 2023 May;12(10):11264-11273. doi: 10.1002/cam4.5835. Epub 2023 Apr 6. Cancer Med. 2023. PMID: 37021926 Free PMC article.
High-dose cytarabine induction therapy and flow cytometric measurable residual disease monitoring for children with acute myeloid leukemia.
Tomizawa D, Matsubayashi J, Iwamoto S, Hiramatsu H, Hasegawa D, Moritake H, Hasegawa D, Terui K, Hama A, Tsujimoto SI, Kiyokawa N, Miyachi H, Deguchi T, Hashii Y, Iijima-Yamashita Y, Taki T, Noguchi Y, Koike K, Koh K, Yuza Y, Moriya Saito A, Horibe K, Taga T, Tanaka S, Adachi S. Tomizawa D, et al. Among authors: tsujimoto si. Leukemia. 2024 Jan;38(1):202-206. doi: 10.1038/s41375-023-02075-9. Epub 2023 Nov 6. Leukemia. 2024. PMID: 37926712 No abstract available.
Genome-wide DNA methylation analysis in pediatric acute myeloid leukemia.
Yamato G, Kawai T, Shiba N, Ikeda J, Hara Y, Ohki K, Tsujimoto SI, Kaburagi T, Yoshida K, Shiraishi Y, Miyano S, Kiyokawa N, Tomizawa D, Shimada A, Sotomatsu M, Arakawa H, Adachi S, Taga T, Horibe K, Ogawa S, Hata K, Hayashi Y. Yamato G, et al. Among authors: tsujimoto si. Blood Adv. 2022 Jun 14;6(11):3207-3219. doi: 10.1182/bloodadvances.2021005381. Blood Adv. 2022. PMID: 35008106 Free PMC article.
Severe RAS-Associated Lymphoproliferative Disease Case with Increasing αβ Double-Negative T Cells with Atypical Features.
Kurita D, Shiba N, Ohya T, Murase A, Shimosato Y, Yoshitomi M, Hattori S, Sasaki K, Nishimura K, Tsujimoto SI, Takeuchi M, Tanoshima R, Kanegane H, Kitagawa N, Ito S. Kurita D, et al. Among authors: tsujimoto si. J Clin Immunol. 2023 Nov;43(8):1992-1996. doi: 10.1007/s10875-023-01566-9. Epub 2023 Aug 29. J Clin Immunol. 2023. PMID: 37644277
Assessing the efficacy of target adaptive sampling long-read sequencing through hereditary cancer patient genomes.
Nakamura W, Hirata M, Oda S, Chiba K, Okada A, Mateos RN, Sugawa M, Iida N, Ushiama M, Tanabe N, Sakamoto H, Sekine S, Hirasawa A, Kawai Y, Tokunaga K; NCBN Controls WGS Consortium; Tsujimoto SI, Shiba N, Ito S, Yoshida T, Shiraishi Y. Nakamura W, et al. Among authors: tsujimoto si. NPJ Genom Med. 2024 Feb 17;9(1):11. doi: 10.1038/s41525-024-00394-z. NPJ Genom Med. 2024. PMID: 38368425 Free PMC article.
Low NUDT15 expression levels due to biallelic NUDT15 variants and 6-mercaptopurine intolerance.
Yoshida M, Brown SA, Moriyama T, Nishii R, Tsujimoto SI, Yamada Y, Yoshida K, Shirai R, Osumi T, Utano T, Fukano R, Kudo K, Sakaguchi K, Arakawa Y, Koh K, Sekiguchi M, Sekimizu M, Miyamura T, Ishida H, Inukai T, Tomizawa D, Kiyokawa N, Kato M, Yang JJ. Yoshida M, et al. Among authors: tsujimoto si. Br J Haematol. 2022 Oct;199(2):270-276. doi: 10.1111/bjh.18375. Epub 2022 Jul 29. Br J Haematol. 2022. PMID: 35905175 Free PMC article.
Relationship between Sedative Antihistamines and the Duration of Febrile Seizures.
Daida A, Yamanaka G, Tsujimoto SI, Yokoyama M, Hayashi K, Urayama KY, Ishida Y, Manabe A, Kusakawa I, Ogihara M, Kawashima H. Daida A, et al. Among authors: tsujimoto si. Neuropediatrics. 2020 Apr;51(2):154-159. doi: 10.1055/s-0040-1701226. Epub 2020 Jan 14. Neuropediatrics. 2020. PMID: 31935762
Recurrent RARB Translocations in Acute Promyelocytic Leukemia Lacking RARA Translocation.
Osumi T, Tsujimoto SI, Tamura M, Uchiyama M, Nakabayashi K, Okamura K, Yoshida M, Tomizawa D, Watanabe A, Takahashi H, Hori T, Yamamoto S, Hamamoto K, Migita M, Ogata-Kawata H, Uchiyama T, Kizawa H, Ueno-Yokohata H, Shirai R, Seki M, Ohki K, Takita J, Inukai T, Ogawa S, Kitamura T, Matsumoto K, Hata K, Kiyokawa N, Goyama S, Kato M. Osumi T, et al. Among authors: tsujimoto si. Cancer Res. 2018 Aug 15;78(16):4452-4458. doi: 10.1158/0008-5472.CAN-18-0840. Epub 2018 Jun 19. Cancer Res. 2018. PMID: 29921692
28 results